Product Information

BACLOFEN 20 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0569 per EA under NDC 16571017250. Its NADAC has been published 120 times since Aug 7, 2024.

FDA first approved this application on Mar 5, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BACLOFEN 20 MG TABLET

BACLOFEN
$0.0569per EA

Strength

20 mg/1

NDC

16571017250

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

BACLOFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA214374

FDA Approved

3/5/2021

TE Code

AB

On Market Since

3/1/2024

Pharmacological Classes

GABA A Agonists
GABA B Agonists
gamma-Aminobutyric Acid-ergic Agonist

Price Statistics

The NADAC for BACLOFEN 20 MG TABLET has been published 120 times since Aug 7, 2024, and over the history we have for it it has risen 6.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0569 per EA
All-time high$0.0691 (Sep 11, 2024)
All-time low$0.0463 (Nov 20, 2024)
52-week high$0.0569
52-week low$0.0509
Median price$0.0545
Average price$0.0550
Largest weekly change+29.3% (Aug 21, 2024)
Weeks tracked120
Tracking sinceAug 7, 2024

Price History

1W

+4.4%

1M

+9.8%

3M

+11.9%

6M

+2.4%

1Y

+6.1%

3Y

N/A

5Y

N/A

All

+6.6%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BACLOFEN 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BACLOFEN 20 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0569 per EA (NDC 16571017250), effective Nov 18, 2026.

How has the price of BACLOFEN 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for BACLOFEN 20 MG TABLET has risen 6.6%. It has been tracked across 120 weekly CMS publications since Aug 7, 2024.

What are the highest and lowest recorded NADAC prices for BACLOFEN 20 MG TABLET?

Since Aug 7, 2024, the NADAC for BACLOFEN 20 MG TABLET has ranged from a low of $0.0463 (Nov 20, 2024) to a high of $0.0691 (Sep 11, 2024), with a median of $0.0545 per EA.

Are there cheaper alternatives to BACLOFEN 20 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BACLOFEN 20 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BACLOFEN 20 MG TABLET?

BACLOFEN 20 MG TABLET (NDC 16571017250) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.